Bicara Therapeutics Inc. (BCAX)

NASDAQ: BCAX · Real-Time Price · USD

12.62

-0.29 (-2.25%)

At close: Jan 31, 2025, 4:00 PM

13.25

+0.63 (4.99%)

After-hours: Jan 31, 2025, 5:46 PM EST

Bicara Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022
Period Ending	Jan '25 Jan 31, 2025	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	687	-	-
Enterprise Value	166	-	-
Debt / Equity Ratio	0.00	0.00	-
Quick Ratio	35.96	15.28	0.17
Current Ratio	36.01	15.32	0.21
Return on Equity (ROE)	-	-51.67%	-
Return on Assets (ROA)	-	-20.72%	-
Return on Capital (ROIC)	-	-24.70%	-
Buyback Yield / Dilution	-666.34%	-35.20%	-
Total Shareholder Return	-666.34%	-35.20%	-

Source: S&P Capital IQ. Standard template. Financial Sources.